Cardiovascular Systems Physiology and Pathophysiology VI Flashcards
Defined as the presence of a severe and constricting pain
Angina
Severe and constricting pain that occurs within the chest and is due to ischemia
Angina pectoralis
The discomfort associated with angina pectoralis is usually
Retrosternal (can radiate to shoulders, neck, backand/or jaw)
The pathogenesis of the signs and symptoms of angina pectoris is explained by ischemia within one or more regions of the
Ventricular myocardium
A specific form of angina, and results from a fixed narrowing of one or more coronary vessels; generally due to atheromatous plaque formation
Chronic stable angina
With chronic stable angina, as cardiac demand is upregulated (such as after exercise or a big meal) O2 supply an not meet demand, which sets a cascade of events in place leading to
Impaired LV function
Characterized by an increase in LV diastolic pressure and LV wall tension, which collectively overburden the already O2 starved myocytes
Chronic stable angina
Signs and symptoms of stable angina result from impeded O2 delivery, and include
Diffuse retrosternal tightness and pressure
Physical exam during an episode of chronic stable angina would likely reveal
Elevated BP and an S4 gallop (due to decreased LV compliance)
Would show horizontal or downsloping ST depression and T wave inversions or flattening over ischemic regions
ECG of stable angina
What can be used to treat and manage angina?
Vasodilators and negative inotropic agents
What are some common vasodilators that could be used to treat angina?
- ) Nitroglycerine
2. ) Ca2+ channel blockers such as: amlodipine, diltaizem, and verapamil
What are some negative inotropic agents that could be used to treat angina?
Beta bockers and Ca2+ channel antagonists
Each decrease Ca2+ current in the SA and AV nodes
Beta blockers and Ca2+ channel antagonists
Drug to treat angina that impairs the late Na+ current that is present in cardiomyocytes which helps to restore NCX activity
Ranolazine
In angina, there is a prolonged phase of terminal Na+ current. This impedes NCX function and results in increased intracellular Ca2+ which promotes a state of increased
LV wall tension(thus increasing O2 demand)
The only blood vessels that do not contian any form of vascular smooth mucle
Capillaries
Innervate predominantly the microcirculatory beds within the GI, genito-urinary, respiratory, salivatory, ocular, and cerebral tissues
PSNS efferents
PSNS-induced changes in vascular resistance in
the aforementioned do not translate into significant alterations in
Systemic BP
PSNS activity is not traditionally associated with antagonizing SNS vasoconstriction to lower BP Instead, PSNS activity enables more localized changes in blood flow in order to aid in
Tissue metabolism
SNS fibers innervate
Arteries, arterioles, venules, and veins
By and large, SNS fibers induce vasoconstriction via
Norepinephrine and a1 receptors
SNS is typically responsible for the interplay between vasoconstriction and dilation. However, in some tissue beds, vasodilation can be induced by
-ex skeletal muscle
B2 adrenergic receptors
What does SNS-dependent vasoconstriction result in in
- ) Arterioles
- ) Venules
- ) Increased TPR
2. ) Does not effect TPR but enhances venous return
Increased venous return increases
Cardiac output
A large bed which receives about 25% of CO and can accommodate upwards of 20% of total blood volume
Splanchnic circulation (that within the gut)
Highly endowed with a1 adrenoreceptors when compared to other venous beds
- extremely sensitive to any increase in SNS tone
- contains high compliance veins
Splanchnic circulation
Venoconstriction of the splanchnic venous tissues results in mobilization of venous blood volume from this bed for
Venous return to the RA
Collectively increases arterial BP by increasing TPR and upregulating venous return and cardiac output
SNS
Graded by the amount and type of neurotransmitter that is released in response to the efferent signal
SNS stimulation
In response to initial efferent tone, post-ganglionic SNS fibers release norepi, and norepi which activates
-provides an early phase for a low degree of vasoconstriction
Type a1 adrenergic receptors
As the efferent signal increases to moderate intensities, the noradrenergic system is complemented by the
release of
ATP
Acts as a neurotransmitter since is stimulates post-junctional purinoreceptors
ATP
Together, cause a greater stimulation of smooth muscle contraction than would occur in the presence of norepi alone
Norepinephrine and ATP
What happens in the event of intense efferent SNS tone?
Norepinephrine secretion is elevated
-ATP secretion ceases
NP-y secretion is stimulated
Binds and activates so-called Y receptors on the pot-junctional smooth muscle membrane and functions as a synergist to norepinephrine
NP-Y
A potent vasoconstrictor that is synthesized from the renal hormone, renin, via a multi-step process
Angiotensin-II (An-II)
Acts through a receptor mediated process to stimulate vasoconstriction
-also can bind SNS post-ganglionic pre-junctional receptors to stimulate Norepinephrine secretion
An-II
Receptors that are coupled to the release of norepinephrine and are activated in the face of chronically elevated epinephrine
Pre-junctional B2 receptors